Show simple item record

dc.contributor.authorVossenkamper, A
dc.contributor.authorMacDonald, TT
dc.contributor.authorMarches, O
dc.date.accessioned2011-08-10T11:26:31Z
dc.date.issued2011
dc.identifier.otherdoi:10.1186/1476-9255-8-11
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/1797
dc.description.abstractThe intestinal immune system and the epithelium are the first line of defense in the gut. Constantly exposed to microorganisms from the environment, the gut has complex defense mechanisms to prevent infections, as well as regulatory pathways to tolerate commensal bacteria and food antigens. Intestinal pathogens have developed strategies to regulate intestinal immunity and inflammation in order to establish or prolong infection. The organisms that employ a type III secretion system use a molecular syringe to deliver effector proteins into the cytoplasm of host cells. These effectors target the host cell cytoskeleton, cell organelles and signaling pathways. This review addresses the multiple mechanisms by which the type III secretion system targets the intestinal immune response, with a special focus on pathogenic E. coli.
dc.rightsCreative Commons Attribution License: http://creativecommons.org/licenses/by/2.0/
dc.subjectgut-associated lymphoid tissue
dc.subjecttype 3 secretion system
dc.subjectEPEC
dc.subjectShigella
dc.titleAlways one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system
dc.identifier.doi10.1186/1476-9255-8-11
dc.relation.isPartOfJ Inflammation
pubs.declined2011-08-03T11:16:26.784+0100
pubs.issue8
pubs.publication-statusPublished
pubs.publisher-urlhttp://www.journal-inflammation.com/content/8/1/11
pubs.publisher-urlhttp://www.journal-inflammation.com/content/8/1/11
pubs.volume11


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record